InvestorsHub Logo

richme

01/22/15 10:23 PM

#141919 RE: sitten-bull #141917

Elite has revenues but not enough to float the bloated bureaucracy therefore the dilution which cannot be supported by the few generics in the market. We need revenues that produce profits and I don't mean the bs kind.

straitfan

01/22/15 11:54 PM

#141921 RE: sitten-bull #141917

You keep missing the key point; R&D companies are not revenue driven.